Read about the world-class talent recruited into MAHSC and the initiatives that we believe will attract more experts from around the globe.
Professor Karen Kirkby appointed as Chair in Proton Beam Therapy
Karen will be responsible for developing a programme of international leading proton research and innovation to deliver direct patient benefits. This goes from basic research, through pre-clinical and translational research to clinical trials and offers patients increased choices and expansion of treatment available. It also seeks to increase grant and commercial funding for clinical research as well as developing local and international proton research collaborations.
Professor Marcel Van Herck appointed as Chair in Radiotherapy Physics
Marcel is the recipient of first prize of the European Society for Radiotherapy and Oncology ESTRO-Varian Clinical Research Award, the “Antoni van Leeuwenhoek Award” ( Both awards relate to work on an Electronic Portal Imaging Device) and he was also award the Breur Award at ESTRO. Marcel takes up the post of Chair in Radiotherapy physics at the Christie from April 2015 bringing a wealth of expertise and academic leadership to further enhance Radiotherapy research.
Professor Andrew Hughes appointed as Chair in Cancer Experimental Therapeutics at The University of Manchester and Strategic Director of the Experimental Cancer Medicine team
Andrew was previously Vice-President for early oncology clinical development at AstraZeneca and has held a joint appointment with The University of Manchester as Chair in Experimental Cancer Therapeutics since 2008. His expertise in the development of new cancer medicines and leadership experience will be vital to achieving Manchester’s ambition to become one of the largest centres for experimental cancer medicine trials worldwide.